Kura Oncology, Inc. (NASDAQ:KURA) Receives $28.36 Average Price Target from Analysts

Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average […]

Leave a Reply

Your email address will not be published.

Previous post Robert W. Baird Boosts Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $60.00
Next post Academy Sports and Outdoors, Inc. (NASDAQ:ASO) Receives $67.87 Consensus PT from Brokerages